key: cord-0751320-cnxur48e
authors: Huisman, J. S.; Scire, J.; Caduff, L.; Fernandez-Cassi, X.; Ganesanandamoorthy, P.; Kull, A.; Scheidegger, A.; Stachler, E.; Boehm, A. B.; Hughes, B.; Knudson, A.; Topol, A.; Wigginton, K. R.; Wolfe, M. K.; Kohn, T.; Ort, C.; Stadler, T.; Julian, T. R.
title: Wastewater-based estimation of the effective reproductive number of SARS-CoV-2
date: 2021-04-30
journal: nan
DOI: 10.1101/2021.04.29.21255961
sha: 764868daab30bdf5353206f5bc2856cf8f7d9af3
doc_id: 751320
cord_uid: cnxur48e

The effective reproductive number, Re, is a critical indicator to monitor disease dynamics, inform regional and national policies, and estimate the effectiveness of interventions. It describes the average number of new infections caused by a single infectious person through time. To date, Re estimates are based on clinical data such as observed cases, hospitalizations, and/or deaths. Here we show that the dynamics of SARS-CoV-2 RNA in wastewater can be used to estimate Re in near real-time, independent of clinical data and without associated biases stemming from clinical testing and reporting strategies. The method to estimate Re from wastewater is robust and applicable to data from different countries and wastewater matrices. The resulting estimates are as similar to the Re estimates from case report data as Re estimates based on observed cases, hospitalizations, and deaths are among each other. We further provide details on the effect of sampling frequency and the shedding load distribution on the ability to infer Re. To our knowledge, this is the first time Re has been estimated from wastewater. This method provides a low cost, rapid, and independent way to inform SARS-CoV-2 monitoring during the ongoing pandemic and is applicable to future wastewater-based epidemiology targeting other pathogens.

The effective reproductive number, Re, is a critical indicator to monitor disease dynamics, inform regional and national policies, and estimate the effectiveness of interventions. It describes the average number of new infections caused by a single infectious person through time. To date, Re estimates are based on clinical data such as observed cases, hospitalizations, and/or deaths. Here we show that the dynamics of SARS-CoV-2 RNA in wastewater can be used to estimate Re in near real-time, independent of clinical data and without associated biases stemming from clinical testing and reporting strategies. The method to estimate Re from wastewater is robust and applicable to data from different countries and wastewater matrices. The resulting estimates are as similar to the Re estimates from case report data as Re estimates based on observed cases, hospitalizations, and deaths are among each other. We further provide details on the effect of sampling frequency and the shedding load distribution on the ability to infer Re. To our knowledge, this is the first time Re has been estimated from wastewater. This method provides a low cost, rapid, and independent way to inform SARS-CoV-2 monitoring during the ongoing pandemic and is applicable to future wastewater-based epidemiology targeting other pathogens.

The effective reproductive number, Re, is widely used during the COVID-19 pandemic to track disease dynamics, inform regional and national policies, and estimate the effectiveness of interventions. Re is typically estimated from clinical case data, and can be biased by e.g. changes in testing and reporting. We show longitudinal measurements of SARS-CoV-2 RNA in wastewater can be used to estimate Re, across different regions, and provide an independent assessment of the dynamics of COVID-19. Given widespread wastewater sampling during this pandemic, these Re estimates are directly applicable as a rapid, low-cost method to inform public health policy. The method can be adapted to other pathogens, including those for which clinical data is not available.

A critical quantity to monitor an ongoing epidemic is the effective reproductive number Re (1) (2) (3) (4) . Re describes the average number of new infections caused by a single infectious person, at a given point in time. Typically, Re is estimated from case report data (hereafter referred to as Rcc), including the numbers of new clinical cases, hospitalizations, and deaths (1, (3) (4) (5) . Here, we show that viral RNA concentrations measured in wastewater provide an independent data set to estimate Re (hereafter referred to as Rww). This complements existing Rcc estimates to provide a more complete picture of transmission dynamics.

Re estimates for SARS-CoV-2 are used to inform regional and national policies (6, 7) . The Re changes through time and reflects changes in the immune status of the population, policy, climate, and/or individual behaviours (1, 2) . It can thus be used to estimate the effectiveness of non-pharmaceutical interventions in disease control (5, (8) (9) (10) (11) . However, Rcc estimates have some notable drawbacks. Most importantly, they depend on robust and accurate clinical case surveillance and reporting. Temporal changes in testing capacity, hospitalisation criteria, or the definition of COVID-19-related deaths can bias the Rcc estimates (1, 12) . These estimates are also inferred with a delay: Rcc is estimable once the infections occurring on that day tested positive and were reported as clinical cases (1, 2) . Knowledge of this delay is necessary to accurately infer Rcc, yet differs through time and space, thus limiting comparability across geographic regions. Wastewater data may provide an advantage over clinical case data in all these aspects. SARS-CoV-2 RNA measurements in wastewater can be used to understand COVID-19 epidemiology because infected individuals shed the virus into the sewer system throughout their infection. During the COVID-19 pandemic, SARS-CoV-2 RNA has been repeatedly detected in wastewater and sewage sludge globally (13) (14) (15) (16) (17) (18) (19) , and measured RNA concentrations or loads correlate with clinical case data (13) (14) (15) 17) . Detection of SARS-CoV-2 RNA in the wastewater implies there is at least one actively shedding infected person in the catchment served by the sewer system. Compared to clinical testing, substantially fewer wastewater samples are required to track changes in infection incidence at the community level. Wastewater data has also been integrated into compartmental models of infectious disease transmission, allowing estimation of epidemiological parameters including incidence and the basic reproductive number R0 (20, 21) . Model results generally fall within the confidence intervals of estimates based on clinical case data, supporting the use of SARS-CoV-2 RNA measurements in wastewater to inform disease transmission dynamics.

Models relating SARS-CoV-2 RNA in wastewater to incidence or transmission rates are driven by assumptions of virus excretion rates into the sewer system. Excretion (via feces, saliva, and/or sputum) varies by individual and through time after infection. Generally, this can be described using a shedding load profile, which captures both the temporal dynamics of shedding (in the shedding load distribution; SLD), and the total amount of virus shed by an infected individual. Clinical studies in various settings have measured shedding from symptom onset onwards. Notable examples include Wölfel et al., who measured virus concentrations in the stool of hospitalised patients (21, 22) and Han et al., who included symptomatic and asymptomatic children (23) . Benefield et al. combined such studies into a systematic review of SARS-CoV-2 viral loads (24) . However, little is known about shedding prior to symptom onset. Given uncertainty and variation in estimates of SLDs, modeling approaches to relate wastewater to transmission have varied. For example, Kaplan et al. used an infectivity profile (based on virus concentrations in the upper and lower respiratory tract from Li et al.) rather than information on gastrointestinal shedding to estimate the basic reproductive number R0 from wastewater data (20, 25) . More work is needed to determine both the SLD and the amount of virus shed during an infection to relate SARS-CoV-2 RNA measurements in wastewater to epidemiology.

We measure SARS-CoV-2 RNA in sewage sludge or wastewater from two distinct monitoring programs (Zurich, Switzerland and Bay Area, CA, USA), use the measured RNA to estimate Rww, and compare the estimates to Rcc obtained from clinical case data. We further determine the SLD that optimises the fit between Rww and Rcc and compare it to previously reported SLDs. We find that Rww is a useful metric to monitor the transmission dynamics of SARS-CoV-2, independent from clinical case data. To our knowledge, this is the first time Re has been estimated from pathogen concentrations in wastewater.

SARS-CoV-2 RNA in Wastewater. We tracked SARS-CoV-2 RNA concentrations in Zurich, Switzerland and San Jose, California, USA during a rise and fall in clinical COVID-19 cases (Fig. 1A,B; Fig. 2A ,B). Data from Zurich were used to develop and assess Rww estimates, and data from San Jose were used to assess the generalizability of the approach.

In Zurich, SARS-CoV-2 N1 and N2 markers of the N gene were detectable in the raw influent samples from the Zurich wastewater treatment plant between 1 September 2020 and 20 January 2021 in all 105 samples collected (Fig. 1A ). Of these, 102 were above the limit of quantification. Concentrations were multiplied by daily flow rate to estimate total number of gene copies shed by people within the catchment per day (hereafter referred to as loads), resulting in median [range] loads of 13.4 [<12 (limit of detection), 13.7] log10 gene copies per day (gc/day) (Fig. 1A ). Only one sample (29 October) was excluded based on quality control, which included monitoring sample inhibition and consistency of effluent pepper mild mottle virus (PMMoV) loads (see Supplemental Material).

In San Jose, SARS-CoV-2 N, S, and ORF1a genes were quantifiable in the settled solids of the primary settling tank in all 125 samples collected between 15 November 2020 and 19 March 2021 ( Fig. 2A) . The median [range] concentrations were 4.9 [3.4, 6.0], 5.0 [3.9, 6.0], and 5.0 [3.8, 6 .0] log10 gene copies per gram dry weight (gc/g-dry weight) for N, S, and ORF1a genes, respectively ( Fig. 2A) . Two samples (03 January, 18 February) were excluded based on quality control using consistency of PMMoV concentrations (see Supplemental Material). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint Infection incidence dynamics can be inferred from wastewater measurements. Next, we related the RNA measurements in wastewater to the original infection incidence by applying a deconvolution with the shedding load distribution (see Methods). SARS-CoV-2 wastewater measurements reflect the cumulative contributions of all infected individuals actively shedding virus into the wastewater. The amount of virus shed by each individual varies through time after infection, and is captured in the shedding load profile. In general, this profile contains information about the timing of viral shedding -the shedding load distribution (SLD; which sums to 1) -and the total amount of virus shed -captured by a normalisation factor N. To estimate the true number of infections in the sewer shed it is important to estimate the exact value of the normalisation factor N, as well as a factor M describing losses along the way from shedding to sample processing. However, to estimate Re it suffices to know the temporal dynamics of shedding and infection (see Methods). As a first approximation, we assumed individuals do not shed prior to symptom onset, and thereafter shed according to the gastrointestinal SLD reported by Benefield et al. (24) . With this assumption, we found that the dynamics of infection incidence inferred from wastewater measurements in Zurich are similar to the dynamics inferred from clinical case data (Fig. 1C) . We later test the sensitivity of our results to the assumed SLD and normalisation.

The effective reproductive number Rww can be estimated from RNA measurements in wastewater. We used the inferred time series of infection incidence from SARS-CoV-2 RNA measured in wastewater to estimate Rww in Zurich ( Fig. 1D ; see Methods). There is a good correspondence between Rww and Rcc. In fact, the average root mean squared error (RMSE) between Rww and Rcc is 0.11 and 0.12 for N1 and N2 respectively. This is smaller than the RMSE between the Re estimates based on different sources of case report data: 0.13 between confirmed cases and hospitalisations; and 0.26 between confirmed cases and deaths (estimated on case report data from canton Zurich, which has a population 3.4x the size of the catchment, for the same time period as Rww). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint

To test whether these results could be generalised to different geographic locations and wastewater matrices, we analysed daily-sampled primary sewage sludge data from the San Jose wastewater treatment plant in California.

In San Jose, the inferred infection incidence curves between confirmed cases and wastewater data follow similar trends (Fig. 2C) . However, confirmed cases rise rapidly reaching a maximum and fluctuating at a plateau throughout December, whereas wastewater estimates continue to rise more gradually throughout this period (Fig. 2C) . This difference is likely due to underreporting of cases during the holidays, as the testing-adjusted cases followed a trend more similar to the wastewater measurements (Fig. S1A ). Starting in late December, both wastewater and cases show a similarly rapid decrease.

We found that Rww agreed with Rcc, although there is some temporal lag between both time series (Fig. 2D ). In general, both Rww or Rcc could be inaccurately placed in time: e.g. because the SLD does not optimally capture the shedding dynamics, or because reporting delays for the clinical cases changed during the observation period. In this case, it seems likely that the Rcc estimates are biased by underreporting and increased testing delays. Re estimates based on the cases adjusted for testing show results more comparable to Rww, especially in November/December (Fig. S1B) . Furthermore, there are substantially larger differences between Rcc estimated using different methods (as reported on the website of the California State Department of Public Health), than between the wastewater and the confirmed case trace estimated using the same pipeline (Fig. S2 ).

Minimal Frequency of Wastewater Sampling needed to inform Rww. While designing wastewater-based epidemiology studies, an important cost-benefit trade-off centers around the frequency of sampling. We subsampled the daily sampled wastewater measurements in Zurich and San Jose, prior to the Re estimation pipeline, to determine how this would affect the estimated Rww. We assessed a range of sampling strategies that differed in the number and identity of the days sampled (e.g. Mon-Wed-Fri or Tue-Fri). For Zurich, we restricted ourselves to the period with daily sampling (22 November 2020 to 11 January 2021). Using the RMSE to quantify the similarity between different Rww estimates, we found that subsampling down to 3 measurements per week still leads to results comparable to a daily sampling regime (Fig. S3 , Table S1, Table S2 ). However, below this frequency the representativity of the Rww estimate starts to depend on which days were sampled.

Susceptibility of Rww estimates to the shedding load distribution. We showed that Re can be estimated from RNA measurements in wastewater, given an assumption for the SLD. However, there is substantial variation between SLDs described in the literature, across patients, bodily fluids, and geographic locations. The shape of the SLD, in particular the mean of the gamma distribution used, affects the inferred timing of peak infection incidence (Fig. S4 ). In our pipeline we also observe an influence of the normalisation factor N*M on the amplitude of the estimated Rww (Fig. S5 ). In principle, the inference of the Re point estimate from an infection incidence is agnostic to the magnitude of this incidence (2, 4) . However, the noise model and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint deconvolution algorithm in our pipeline were optimised for data on the scale of infections per day. Here, we have chosen to normalise the wastewater measurements such that the considered gene loads are on that same scale, since Rww otherwise reacts too strongly to changes in the daily incidence (Fig. S5) .

Estimation of the shedding load distribution that optimizes the fit between clinical and wastewater data. Instead of assuming a single SLD and estimating Rww based only on that distribution, we also asked which SLD would maximise the similarity between the Rww and Rcc estimates. We numerically scanned across different SLDs and quantified the resulting goodness of fit between the Rww and Rcc for both Zurich and San Jose. We assumed the SLD is described by a single gamma distribution, starting at infection, and searched for the optimal fit on a grid of mean-standard deviation parameter pairs (Table 1, Fig. 3 ). The fit was quantified using the root mean squared error (RMSE), coverage, and mean absolute percentage error (MAPE; see Methods).

The optimal fits based on these metrics suggest that the SLD has a mean between 7-11 days in Zurich and 5-7 days in San Jose, with a very low standard deviation of 0.5 days in both locations (Table 1) . However, there is some non-identifiability in our analysis, with most optimal value pairs lying along a ridge (Figs. 3, S6, S7). This ridge corresponds to SLDs with a similar median, which result in nearly indistinguishable Rww estimates (Fig. S8 ). If we consider the parameters yielding a fit within 10% from the optimum, the parameter ranges found in both locations are compatible and jointly suggest an SLD with mean between 6-9 days, and standard deviation between 0.5-3 days. Longer time series and more locations would further constrain this distribution. Compared to the delay between infection and case reporting, the SLD introduces a similar or lower mean delay to Rww. For Zurich, the cases were delayed with respect to infection by 8.1 days on average (see Methods), which is comparable to the 6-9 days for Rww. For San Jose, instead, the delay distribution of the case report data had a mean of 9.8 days. There, the wastewater may lead the confirmed cases by 1-4 days, if the current testing and reporting regime is upheld.

To compare against published SLDs, which are frequently parameterized from symptom onset instead of infection, we conducted a second analysis. Here we assumed individuals do not shed during their incubation period and subsequently shed with a gamma distribution, starting at symptom onset. In this case, we find optimal SLDs with a mean between 0.5-3 days for San Jose and 3.5-5.5 days for Zurich (Table S3, (23, 24) . If we add the mean incubation period (5.3 days) to the results of this scan, we find that for both locations the mean delay between infection and shedding is comparable to the mean of the SLD we estimated from infection.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint Fig. 3 : RMSE between Rcc and Rww for different shedding load distributions. We scanned across different (mean, standard deviation) parameter pairs for the SLD from time since infection. For the city of Zurich, the Rww from N1 loads in wastewater was compared to that of confirmed cases in the catchment. For San Jose, we compared S gene concentrations to confirmed cases in Santa Clara County. The contour lines show SLD parameter pairs with equal RMSE, in steps of 10% of the optimum value. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021.

We showed that regular measurements of SARS-CoV-2 concentrations in wastewater and settled solids can be used to estimate the effective reproductive number Re. The variation between Re estimates from wastewater (Rww) and from case report data (Rcc) is similar to the variation between Re estimates based on different types of case report data (clinical cases, hospitalizations, and deaths). We further showed wastewater samples should be collected at least 3 times per week to reliably estimate past Rww, in line with analyses based on direct comparison of wastewater signals to clinical cases (15, 26) . For real-time monitoring of Rww, more frequent measurements may be preferable to ensure stable estimates when new data comes in.

Estimating Rww requires accurate characterization of the SLD, i.e. the temporal dynamics of shedding. In our primary analysis, we used the distribution for gastrointestinal shedding from Benefield et al. (24) . In using this SLD, we implicitly assumed that fecal shedding dominates the viral load in wastewater. However, there is a wide range in published viral shedding loads, and it is unclear which -if any -accurately capture viral shedding dynamics of people within a catchment. Virus shed in saliva, sputum, and feces are possible contributors to the total amount of virus RNA in the wastewater (27) . While upper respiratory tract swabs show peak viral loads around the day of symptom onset, there are indications that sputum samples peak a few days later, and feces even after that (28) (29) (30) . Studies differ in the inferred timing of peak viral load (even in the same bodily fluids), and there is a general lack of information to constrain dynamics prior to symptom onset (31) . Additionally, the duration and magnitude of viral shedding seem to differ within different populations (for example, due to age or severity of disease) (32, 33) . However, these individual differences will probably average out in a sufficiently large catchment and better estimates of the SLD are likely to become available as prospective sampling studies report results.

We showed that the optimal SLD can also be inferred from the fit between Rww and Rcc. Once the SLD has been estimated from historic wastewater and case data, it may from then on provide a more accurate estimation of Rww, than using one of the published SLDs. Indeed, here we show a range of SLDs inferred from our wastewater data that generally align with, but have lower means than published SLDs based on patient shedding profiles. Optimization based on alignment between Rww and Rcc assumes accuracy of Rcc, which only holds when there is adequate clinical case surveillance. However, given widespread wastewater monitoring coincident to clinical case reporting, broader application of our methods would help constrain the SLD of SARS-CoV-2.

The utility of wastewater measurements for Re estimation is independent of the pipeline used to estimate Re. Here, we report results obtained with the pipeline of Huisman et al. (2) . However, many estimation methods exist, differing in assumptions on smoothing, deconvolution, uncertainty quantification as well as the underlying method to estimate Re from infection incidence (1, 3, 7, 34, 35) . Although the Re point estimate is agnostic to the absolute magnitude of the infection incidence (and thus comparable across wastewater treatment plants with differing sampling protocols), the rest of our pipeline -including the deconvolution and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint estimation of confidence intervals -was originally developed specifically for use with clinical data. Thus, we had to normalise the measured wastewater concentrations to the same order of magnitude as the case data. Further development could make the method more specifically adapted to wastewater data, and alleviate this dependence on the normalisation.

Estimates of Rww are independent of biases influencing clinical case-based estimates. Rcc estimates are based on only the subset of infections, hospitalizations, and/or deaths that are captured by surveillance within the healthcare system. If this subset changes, for instance due to developments in testing or reporting policy, the resulting Rcc estimates will be temporarily biased (2, 4) . In Geneva, Switzerland, seroprevalence studies showed that the number of infections per reported case varied substantially, from an estimated 11.6 infections per reported case as of May 2020 to only 2.7 as of December 2020 (36, 37) . During that period, SARS-CoV-2 RNA concentrations in wastewater better reflected the dynamics than the clinical cases (38) .

However, Rww estimates are also prone to biases. People's behaviours, such as defecation timing outside of a daily routine (39) and/or movement into or out of the catchment (40) can influence Rww estimates, particularly when the number of infected individuals is low. RNA signals may also be impacted during sewer transport, with persistence influenced by environmental conditions (i.e., temperature) and/or sewage composition (i.e., solids content) (41) (42) (43) (44) . Furthermore, sample processing required to quantify SARS-CoV-2 RNA may introduce variation, as suggested by substantial day-to-day variation in measurements (13, 15, 38, 45) . Finally, Rww estimates are informed by the number and proportion of infected and/or shedding people within the catchment: if there are too few active shedders, Rww may be very sensitive to the increased fluctuations in SARS-CoV-2 RNA concentrations.

Deriving Re from wastewater offers an independent method to track disease dynamics. Wastewater-based epidemiology is used globally to track the COVID-19 pandemic (https://www.covid19wbec.org/covidpoops19) (13) (14) (15) (16) (17) (18) (19) . The data collected within these campaigns could be used to estimate Rww with a robust method, not influenced by heterogeneous testing and reporting strategies, and hence more comparable across geographic areas. Additionally, Rww estimates could be derived for the transmission of SARS-CoV-2 variants and/or other pathogens for which SLDs are known. SARS-CoV-2 variants, including Variants of Concern (VOCs), are readily detectable in wastewater (46) (47) (48) as are other pathogens (e.g., norovirus, enterovirus, hepatitis A) (49) (50) (51) . This could provide the temporal, quantitative wastewater measurements needed to estimate Rww. Wastewater surveillance allows estimating Rww to track disease transmission dynamics in near-real time, using low cost, rapid, and geographically-comparable methods, and can be used when reporting clinical cases is not feasible, mandatory, or much delayed compared to infection and shedding.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint

Sample Collection and Preparation. From 03 September 2020 to 19 January 2021, raw influent after fine screening samples (500 ml) were collected and processed from the Werdhölzli wastewater treatment plant (Zurich, CH) to quantify SARS-CoV-2 RNA following the protocol of Fernandez-Cassi et al. 2021 (38) . Samples were collected twice per week (Thursdays, Sundays) until October 29; afterwards, samples were collected almost daily. Until 25 October, samples were processed in duplicate (biological replicates).

Briefly, 24-hour flow-proportional composite samples were collected in 500 mL polystyrene or polypropylene plastic bottles, shipped on ice, and stored at 4°C for up to 8 days before processing. Aliquots (50 mL) were stirred at room temperature for 30 minutes and then clarified by sequential filtration through 2 µm glass fiber pre-filters (Merck) and 0.22 μm SteriCup filters (Merck). The filtrates were concentrated by centrifugation (3000xg for 30 minutes) using Centrifugal Filter Units (10kDa Centricon Plus-70, Millipore, USA), followed by concentrate collection from the inverted filter during 3 min at 1000xg.

RNA Extraction. Concentrate (140-280 μL) was extracted using the QiaAmp Viral RNA MiniKit (Qiagen, USA) according to manufacturer's instructions, adapted to the larger volumes, and using 80 μL eluent volume. RNA extract was quantified immediately or within one week (storage at -80°C) using dPCR for SARS-CoV-2 N gene using both N1 and N2 markers. Separate RNA extract aliquots were stored at -80°C for less than three months for quantification of PMMoV genes. Samples were extracted once, and a negative extraction control using molecular grade water was run in parallel for every batch of extracted samples. (52, 53) . Samples were diluted 10-fold in a single step using molecular grade water before quantification in replicate wells. If the sample concentration was below the limit of quantification (LOQ), an undiluted sample was quantified (see Supplemental Information for LOQ). Positive controls consisting of 100 gc / reaction of synthetic SARS-CoV-2 RNA reference material (EURM-019, Joint Research Center) and negative controls consisting of RNAse/DNAse-free water were included in every thermocycler run. Mastermix, primer and probe sequences, thermocycling conditions, and dMIQE checklist (54) are provided in the Supplemental Information.

Data Analysis and Quality Control. The limit of detection (LOD) and limit of quantification (LOQ) of the N1 and N2 markers were determined by processing 10 replicates of synthetic SARS-CoV-2 RNA reference material at target concentrations of 5, 8, 10, 25, 30, and 50 gc / reaction. LOD . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint was determined to be 8 copies / reaction (equivalent to 2560 copies / L wastewater), with greater than 95% likelihood of detection based on duplicate samples (55) . LOQ was determined to be 25 gc / reaction (equivalent to 8000 gc / L wastewater), which was the lowest concentration with coefficient of variation less than 25% (55) . When sample concentrations were below the LOQ, samples were processed without dilution. If undilute samples remained below LOQ, values were replaced with 16.5 gc/reaction, representing the mean of the LOQ and limit of detection (LOD, 8 gc/reaction, equivalent to 2560 gc/L wastewater).

Pepper Mild Mottle Virus (PMMoV), a plant virus that is found at high and constant concentrations in wastewater, was used as an internal process control to monitor fecal strength and detect anomalies in the collected sample or problems during concentration and extraction. in each sample (53) . Samples with PMMoV loads (log10 gc / day) outside the mean plus or minus three times the standard deviation were excluded from further analysis. SARS-CoV-2 RNA concentrations were converted to loads by multiplying with the WWTP daily flow rate because normalization to flow was found to be superior to PMMoV based on correlation with clinical data (26) .

PCR inhibition was tested by adding 800 genome copies / reaction of synthetic SARS-CoV-2 RNA reference material (EURM-019, Joint Research Center) to the mastermix in separate reactions. Samples were processed at the same dilution used for quantification of the N1 and N2 markers (see Digital and Quantitative PCR). Samples were considered inhibited if either the observed N1 or N2 concentration in the samples with synthetic SARS-CoV-2 RNA (spiked samples) was 80% or less than the sum of the concentration in the unspiked sample plus the concentration in the spiked, sample-free controls. Inhibited samples were removed from further analysis. Briefly, 24-hour composite samples were collected in clean plastic containers, immediately stored at 4°C, and transported to the lab for initial processing within 6 hrs of collection. The solids were dewatered by centrifugation at 24000xg for 30 minutes at 4°C. The supernatant was aspirated and discarded. A 0.5 -1 g aliquot of the dewatered solids was dried at 110°C for 19-24 hrs to determine its dry weight. Dewatered solids were resuspended in Bovine Coronavirus (BCoV)-spiked DNA/RNA shield to a concentration of 75 mg/mL. This concentration of solids represented a concentration at which the inhibition of the SARS-CoV-2 assays was minimized based on experiments with solutions containing varying concentrations of solids (data not shown). BCoV was spiked as an external process control. To homogenize samples, 5-10 5/32" Stainless Steel Grinding Balls (OPS Diagnostics) were added to each sample before shaking with a Geno/Grinder 2010 (Spex SamplePrep). Samples were subsequently briefly centrifuged to remove air bubbles introduced during the homogenization process, and then vortexed to re-. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint mix the sample. Samples were either further processed immediately, or stored at 4°C for processing within 7 days. RNA Extraction. RNA was extracted from 300 µl of homogenized sample using the Chemagic™ Viral DNA/RNA 300 Kit H96 for the Perkin Elmer Chemagic 360 into 60 µl of eluent followed by PCR Inhibitor Removal with the Zymo OneStep-96 PCR Inhibitor Removal Kit (57) . Each sample was extracted ten times. In addition, extraction negative and extraction positive controls, consisting of approximately 500 copies of SARS-CoV-2 genomic RNA (ATCC), were extracted using the same protocol as the homogenized samples in each batch of sample extraction.

Digital PCR. RNA extracts were used as template in digital droplet RT-PCR assays for SARS-CoV-2 N, S, and ORF1a RNA gene targets in a triplex assay, and PMMoV and BCoV in a duplex assay. Undiluted extract was used for the SARS-CoV-2 assay template and a 1:100 dilution of the extract (2 µl into 198 µl molecular grade water) was used for the PMMoV and BCoV assay template. Primer and probe design, primer and probe sequences, mastermix, and thermocycling conditions are described in the Supplemental Information. Each sample was run in 10 replicate wells, extraction negative controls were run in 7 wells, and extraction positive controls in 1 well. In addition, PCR positive controls for SARS-CoV-2 RNA were run in 1 well, and NTC were run in 7 wells. Results from replicate wells were merged for analysis.

Concentrations of RNA targets were converted to concentrations per dry weight of solids in units of gene copies/g dry weight. PMMoV was also used to monitor fecal strength and virus recovery in the San Jose samples, using the same criteria as for the Zurich samples. BCoV was used to assess virus recovery, and samples were removed from further analysis if the amount recovered was less than 10% of the amount added.

To relate the viral RNA loads or concentrations measured in wastewater to the number of new infections per day, we used information on the profile of SARS-CoV-2 RNA shedding into the wastewater by an infected individual in days after infection or symptom onset. In general, this profile contains information about both the magnitude and timing of viral RNA shedding: (i) the SLD w(t) (sums to 1) describes the temporal dynamics of shedding, and (ii) a normalisation factor N describes the total amount of virus shed by an infected individual during the course of infection (in units of gc/infection). After shedding, downstream processes will further affect the total amount of viral RNA sampled per infected individual. We assume this does not affect the temporal dynamics, and can be summarised into a second normalisation factor M. In general, M will depend on the sewer system, wastewater treatment plant, choice of sample matrix and processing pipeline. The units of M differ depending on the way viral concentrations were measured. With these definitions, the measurement Ci of viral RNA in the wastewater on day i is related to past infections Ij on day j:

CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint i.e. the infections are convolved with the SLD.

For the main analysis, we deconvolved by a combination of the incubation period (the time from infection to symptom onset) and the gastrointestinal SLD from Benefield et al. for the time from symptom onset to shedding (24) . Figure 3 from Benefield et al. (24) was digitised manually, and yielded a gamma distribution with mean 6.7 days and standard deviation 7.0 days (38) . For the incubation period, we used the distribution of Linton et al.: a gamma distribution with mean 5.3 days and standard deviation 3.2 days (59) . For additional comparisons (Fig. S2, S3) , we exchanged the Benefield distribution for the SLD upon symptom onset reported by Han et al., gamma distributed with mean 4.7 days, standard deviation 1.7 days (23), or the symptom onset to death delay distribution from Linton et al., gamma distributed with mean 15 days, standard deviation 6.9 days (59).

Since the normalisation factors N and M are difficult to measure, and only influence Rww point estimates when off by several orders of magnitude (Fig. S3 ), we made a simplifying assumption. We assumed the lowest measured RNA load (Zurich) or concentration (San Jose) represents the viral load or concentration from a single infection (N*M). For the Zurich wastewater data, this was 9.7*10^11 gc per infection, and for the San Jose sewage sludge measurements this was 2663.7 gc/g per infection.

The effective reproductive number was estimated from SARS-CoV-2 RNA loads in wastewater or concentrations in sewage sludge using the pipeline developed in (2) . In brief, we first transformed SARS-CoV-2 RNA measurements into a time series of infection incidence. To do so, we filled data gaps through linear interpolation, then smoothed and deconvolved the resulting time series with the SLD to obtain the infection incidence time series. Second, we used the package EpiEstim to estimate the effective reproductive number Re from this infection incidence (4, 60) . The pipeline further accounts for noise in the observation process, by block bootstrapping the observations 50 times prior to smoothing and deconvolution.

The Zurich wastewater estimates were compared to Rcc based on cases reported for the catchment, obtained from the Health Department of Canton Zurich. To estimate Rcc specific to the catchment, we used the pipeline from (2), and deconvolved by a distribution specifying the delay from infection to case confirmation. This was parameterized as the sum of a gamma distributed incubation period with mean 5.3 days, standard deviation 3.2 days (59); and a gamma distributed delay from symptom onset to case confirmation with mean 2.8 days, standard deviation 3.0 days (estimated from line list data for canton Zurich, Sept 2020-Jan 2021). The reported Rcc values for confirmed cases, hospitalisations, and deaths at the cantonal level were taken from https://github.com/covid-19-Re/dailyRe-Data (based on (2)). For the Swiss data, "case confirmation" refers to the earliest recorded date of either a positive test or case reporting.

For comparison to the Californian wastewater data, we downloaded daily COVID-19 case incidence data for Santa Clara County from the California Health and Human Services Open . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint Data portal (https://data.chhs.ca.gov/dataset/covid-19-time-series-metrics-by-county-and-state). The wastewater from Santa Clara County (population of 1.7 million) is nearly all treated at the San Jose wastewater treatment plant (catchment population of 1.5 million). We estimated Rcc using the pipeline from (2) , with the incubation period as before (59) ; and a gamma distributed symptom onset to case reporting delay distribution with a mean of 4.51 days and standard deviation of 3.16 days (estimated from line list data for Santa Clara County in December; based on personal correspondence with the California Department of Public Health COVID-19 modelling team). During the study period, the mean of this distribution varied between 3.31 and 5.24 days, and the standard deviation between 2.32 and 3.55 days. Negative numbers of cases reported (Dec 30) were set to 0. To estimate Re for the testing-adjusted cases, we extracted the daily number of positive tests / total number of tests, multiplied by the mean number of tests (8244.3). This time series was then used to estimate Re, similar to the confirmed cases (with the same delay distribution) (2) . Technically, the tests are reported by testing date, rather than reporting date, so this constitutes a misspecification of the delay distribution. However, an analysis where the delay between symptom onset and testing was assumed 0 did not yield qualitatively different results (not shown). We additionally compared our estimates to the Rcc values for Santa Clara County from the California COVID assessment tool (https://calcat.covid19.ca.gov/cacovidmodels/).

We assessed how well the Re estimates from SARS-CoV-2 concentrations in wastewater (Rww) match those estimated from case report data (Rcc) using several measures. First, the average root mean squared error between both point estimates across the time series ("RMSE"):

where j describes the date, and K the length of the time series. Second, the fraction of dates where the Rww point estimate was within the confidence interval of the Rcc estimate ("coverage"). Third, the mean average percentage error between the time series ("MAPE"):

To investigate optimal parameters for the SLD, we conducted two separate scans. In the first scan, we varied the parameters of the SLD from infection. In the second scan, we estimated the parameters of the SLD from symptom onset onwards. In the latter case, the delay sampled from the SLD was added to a second sampled delay corresponding to the incubation period (gamma distributed with mean 5.3 days and standard deviation of 3.2 days) (59) . In both cases, we assumed the SLD was described by a gamma distribution, and varied the mean μ and standard deviation on a grid (μ ∈ {0.5, 1.0, ..., 15} and ∈ {0.5, 1.0, ..., 10}). The normalisation factor (N*M) was kept fixed to the location-specific value throughout. The Rww for the wastewater data was estimated across 50 bootstrap samples and compared to the Rcc for the catchment.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ;

All code and case data for Zurich are publicly available through the Github repository https://github.com/JSHuisman/wastewaterRe. Wastewater measurements for Zurich are available at DOI: 10.25678/0003VC. Wastewater measurements from San Jose are available by request from ABB (aboehm@stanford.edu), and case data for Santa Clara County is available from the California Health and Human Services Open Data portal (https://data.chhs.ca.gov/dataset/covid-19-time-series-metrics-by-county-and-state). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint Fig. S2 : The estimated Rww in San Jose (black, N gene) compared to different Rcc estimates for Santa Clara county from the CalCat website (https://calcat.covid19.ca.gov/cacovidmodels/). "ETH" refers to the pipeline of Huisman et al. (2) applied to the daily confirmed case data from Santa Clara county, i.e. the same comparison as shown in Fig 2D. We excluded the SEIR model based estimates included on the CalCat website (since these performed visibly worse than the other methods).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint Fig. S5 : The effect of data normalisation on the estimated Rww in Zurich. We calculated Rww from the measured N1 marker indicating the N gene copy loads, normalised in four different ways: by 1x10^12 gc per infection (the order of magnitude of the lowest measured concentration), by 5x10^10gc per infection (roughly rescaled to case incidence), by 1x10^5 gc per infection (to cover the space of possible orders of magnitude), no normalisation. (A) After normalisation the measurements were deconvolved, and rescaled back to the original magnitude (multiplied by the normalisation factor) to illustrate differences in the inferred infection . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint incidence. (B) The resulting Rww estimates differ both in the mean (due to the deconvolution illustrated in A) and width of the uncertainty interval. The results are compared for four SLDs (panels; see Methods): the Benefield SLD upon symptom onset (Incubation + Benefield) (24), the Han SLD upon symptom onset (Incubation + Han) (23, 24) , shedding only on the day of symptom onset (Incubation only), shedding only on the day of death (Incubation + Death) (59) . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) (11 October) was removed from analysis because the dilute sample (1:10) was below LOQ and the undilute sample was inhibited, as defined by recovery of less than 80% of the synthetic SARS-CoV-2 RNA added in.

PMMoV concentrations were obtained for all dates except October 4. Mean (standard deviation) PMMoV loads were 16.5 (0.12) log10 (gc/day). All PMMoV loads fell within 3 standard deviations of the mean, consistent with a normal distribution, except on 29 October (16.1 log10 (gc/day)). The sample was subsequently removed from further analysis. 

The assays used to detect SARS-CoV-2 S, N, and ORF1a genes in San Jose were designed using Primer3Plus (https://primer3plus.com/) based on the genome of the severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1 (Accession Number MN908947.3). The assay was designed to target product size range of 60-200 bp at concentration of dNTPs of 0.8 mM and concentration of divalent cations of 3.8 mM, based on the following optimum (range) conditions: primer size: 20bp (15bp, 36bp); primer melting temperature 60℃ (50℃, 65℃); primer GC content: 50% (40%, 60%); hydrolysis probe size 20bp (15bp, 27bp); hydrolysis probe melting temperature 63℃ (62℃, 70℃); hydrolysis probe GC content: 50% (30%, 80%). The location (length) of the amplicons for N is 28287-28457 (171 bp), S is 23591-23665 (75 bp), and ORF1a is 12885-13063 (179 bp). Cross-reactivity was determined in silico using NCBI Blast. The assays were optimized by varying annealing temperature, and benchmarked against a respiratory virus verification panel using extracted RNA. Limit of the Blank was determined using negative nasal swab samples.

Zurich, Switzerland. Digital RT-PCR was performed on 5 μl template on either the Bio-Rad QX200 Droplet Digital (01 September 2020 -17 October 2020) with the One-Step RT-ddPCR Advanced Kit for Probes (Bio-Rad CN 1864021) or Crystal Digital PCR using the Naica System (Stilla Technologies, 18 October -20 January 2021) with the qScript XLT 1-Step RT-PCR Kit (QuantaBio CN 95132-500). SARS-CoV-2 N1 and N2 markers for the N gene were detected using the 2019-nCoV CDC ddPCR Triplex Probe Assay (Assay ID dEXD28563542, Bio-Rad)

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint according to manufacturer's instructions. For samples processed on the Bio-Rad QX200, 20 µl reaction volumes were prepared in a pre-reaction volume of 22 µl consisting of 5.5 µl of template, 5.5 µl of Supermix, 2.2 µl of Reverse Transcriptase, 1.1 µl of DTT and 1.1 µl of 20x 2019-nCoV CDC ddPCR Triplex Probe Assay. Primers and probes are included in Table S4 . Droplets were generated using the QX100 Droplet Generator (Bio-Rad). PCR was performed on the T100 Thermal Cycler (Bio-Rad) with the following protocol: hold at 25℃ for 3 minutes, reverse transcription at 50℃ for 60 minutes, enzyme activation at 95℃ for 10 minutes, 40 cycles of denaturation at 95℃ for 30 seconds and annealing and extension at 55℃ for 1 minute, enzyme deactivation at 98℃ for 10 minutes, and an indefinite hold at 4℃. Ramp rate was 2℃/second, and the final hold at 4℃ was at least 30 minutes to stabilize droplets. Droplets were analyzed using the QX200 Droplet Reader (Bio-Rad) and thresholding done on the QuantaSoft Analysis Pro Software (Bio-Rad, Version 1.0).

For samples processed on the Crystal Digital PCR, 25 µl reactions were prepared in 27 µl prereaction volumes for Sapphire Chips (Stilla Technologies CN C14012) consisting of 5.4 µl of template, 13.5 µl of 2x qScript XLT One-Step RT-PCR, and 1.35 µl of 20x 2019-nCov CDC ddPCR Triplex Probe Assay. Droplet production and PCR were performed on the Naica Geode with the following protocol: reverse transcription at 48℃ for 50 minutes, denaturation at 94℃ for 3 minutes, followed by 40 cycles of denaturation at 94℃ for 30 seconds, annealing and extension at 57℃ for 1 minute. Chips were read and analyzed on the Naica Prism3 using the Crystal Reader and Crystal Miner software (Stilla Technologies).

For the Bio-Rad QX200 samples with more than 12000 droplets with average partitioning volume of 1 nl was deemed acceptable. For the Stilla Crystal Digital PCR 15000 droplets with average 0.8 nl were deemed acceptable. The average (standard deviation) number of droplets observed in samples from QX200 was 15000 (2100) and for the Crystal Digital PCR excluding controls was 24000 (2000). Average copies per partition (relative uncertainty) was 8.7 x 10 -3 (54%). Every thermal cycler run included one or more no template and positive controls. Samples were deemed successful if the NTCs in the run contained 2 or fewer positive droplets, and the positive controls contained 3 or more. Technical replicate variability was, on average, less than 20%. Inter-experimental variation was quantified as the coefficient of variation in the performance of the positive control (target concentration of 100 gc/reaction) across 87 experiments, and was less than 25%. Assays were only conducted in one laboratory, so reproducibility was not assessed.

PMMoV was quantified by RT-qPCR using RNA UltraSense™ One-Step Quantitative RT-PCR System (Applied Biosystems CN 11732927) on a LightCycler® 480 instrument (Roche Life Science, Switzerland) using previously reported primers and probes (Microsynth AG, Switzerland, Table S4 ) (61, 62) . Samples were prepared in 25 µl reaction volumes consisting of 5 µl of template, 5 µl of 5x Ultrasense Mix, 4 µl of Bovine Serum Albumin (Sigma-Aldrich CN 05470-1G) at 2 mg/ml concentration, 1.25 µl of Reverse Transcriptase, and 2.25 µl of primer and probe at final concentrations of 400 nM and 200 nM, respectively. Primers and Probe are listed in Table S4 . The RT-qPCR was run with the following program: reverse transcription at 55℃ for 60 minutes, denaturation at 95℃ for 10 minutes, followed by 45 cycles of denaturation . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.29.21255961 doi: medRxiv preprint at 95℃ for 15 seconds, annealing and extension at 60℃ for 1 minute. PMMoV quantification was performed by comparison to synthetic DNA standards (gBlock, IDT Technologies) run in duplicate at tenfold dilutions between 5x10 3 and 5x10 7 per 5 µl reaction. All thermal cycler runs were pooled for analysis.

San Jose, California, USA. Digital RT-PCR was performed on 20 µl samples from a 22 µl reaction volume, prepared using 5.5 µl template, mixed with 5.5 µl of One-Step RT-ddPCR Advanced Kit for Probes (Bio-Rad 1863021), 2.2 µl Reverse Transcriptase, 1.1 µl DTT and primers and probes at a final concentration of 900nM and 250nM respectively. Droplets were generated using the AutoDG Automated Droplet Generator (Bio-Rad). PCR was performed using Mastercycler Pro with the following protocol: reverse transcription at 50℃ for 60 minutes, enzyme activation at 95℃ for 5 minutes, 40 cycles of denaturation at 95℃ for 30 seconds and annealing and extension at either 59℃ (for SARS-CoV-2 assay) or 56℃ (for PMMoV/BCoV duplex assay) for 30 seconds, enzyme deactivation at 98℃ for 10 minutes then an indefinite hold at 4℃. The ramp rate for temperature changes were set to 2℃/second and the final hold at 4℃ was performed for a minimum of 30 minutes to allow the droplets to stabilize. Droplets were analyzed using the QX200 Droplet Reader (Bio-Rad), with thresholding done using QuantaSoft™ Analysis Pro Software (Bio-Rad, Version 1.0.596). The average (standard deviation) number of droplets in ten merged wells determined from a random subset of ten samples was 176000 (14500). Average (relative uncertainty) of the number of copies per partition (λ) in the same subset was 3.2x10 -3 (52%). As the samples were extracted ten times and each extract analyzed in one well, technical replicate variability incorporates variation from both RNA extraction and RT-dPCR. Sample errors estimated from the merged wells were <10%, in line with coefficient of variation estimates of <8% for all three targets (S, N, ORF1a) in an experiment of replicate (n = 97) positive controls at target concentrations of 20 gc/µl. Assays were conducted in only one lab, so reproducibility was not assessed. Example fluorescence plots are provided in the associated reference by Topol et al. (58) . All liquid transfers were performed using the Agilent Bravo (Agilent Technologies).

Practical considerations for measuring the effective reproductive number, R t

Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2. medrxiv

Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures

A new framework and software to estimate time-varying reproduction numbers during epidemics

Inferring the effectiveness of government interventions against COVID-19

Verordnung über Massnahmen in der besonderen Lage zur Bekämpfung der Covid-19-Epidemie

Reproduction number (R) and growth rate (r) of the COVID-19 epidemic in the UK: methods of estimation, data sources, causes of heterogeneity, and use as a guide in policy formulation

Non-compulsory measures sufficiently reduced human mobility in Tokyo during the COVID-19 epidemic

Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

The effect of interventions on COVID-19

Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity -United States

Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics

High-Throughput Wastewater SARS-CoV-2 Detection Enables Forecasting of Community Infection Dynamics in San Diego County

SARS-CoV-2 RNA in Wastewater Settled Solids Is Associated with COVID-19 Cases in a Large Urban Sewershed

Long-term monitoring of SARS-CoV-2 RNA in wastewater of the Frankfurt metropolitan area in Southern Germany

Sewage surveillance for the presence of SARS-CoV-2 genome as a useful wastewater based epidemiology (WBE) tracking tool in India

First environmental surveillance for the presence of SARS-CoV-2 RNA in wastewater and river water in Japan

Aligning SARS-CoV-2 indicators via an epidemic model: application to hospital admissions and RNA detection in sewage sludge

COVID-19 Wastewater Epidemiology: A Model to Estimate Infected Populations

Virological assessment of hospitalized patients with COVID-2019

Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19

SARS-CoV-2 viral load peaks prior to symptom onset: a systematic review and individual-pooled analysis of coronavirus viral load from 66 studies

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Evaluation of sampling frequency and normalization of SARS-CoV-2 wastewater concentrations for capturing COVID-19 burdens in the community

SARS-CoV-2 in wastewater: State of the knowledge and research needs

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China

SARS-CoV-2 detection, viral load and infectivity over the course of an infection

Faecal shedding models for SARS-CoV-2 RNA amongst hospitalised patients and implications for wastewater-based epidemiology

Viral dynamics in mild and severe cases of COVID-19

Impact of age on duration of viral RNA shedding in patients with COVID-19

Improved estimation of time-varying reproduction numbers at low case incidence and between epidemic waves. medRxiv

Estimating the time-varying reproduction number of SARS-CoV-2 using national and subnational case counts

SEROCoV-POP): a population-based study

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

Wastewater monitoring outperforms case numbers as a tool to track COVID-19 incidence dynamics when test positivity rates are high https

Defecation frequency and timing, and stool form in the general population: a prospective study

Use of Mobile Device Data To Better Estimate Dynamic Population Size for Wastewater-Based Epidemiology

Challenges in Measuring the Recovery of SARS-CoV-2 from Wastewater

Viability of SARS-CoV-2 in river water and wastewater at different temperatures and solids content

Persistence of SARS-CoV-2 in Water and Wastewater

The detection and stability of the SARS-CoV-2 RNA biomarkers in wastewater influent in Helsinki

Early-pandemic wastewater surveillance of SARS-CoV-2 in Southern Nevada: Methodology, occurrence, and incidence/prevalence considerations

Detection of SARS-CoV-2 variants in Switzerland by genomic analysis of wastewater samples

Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic

Retrospective Surveillance of Wastewater To Examine Seasonal Dynamics of Enterovirus Infections

Temporal dynamics of norovirus determined through monitoring of municipal wastewater by pyrosequencing and virological surveillance of gastroenteritis cases

Identification of multiple potential viral diseases in a large urban center using wastewater surveillance

US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg

Pepper mild mottle virus: A plant pathogen with a greater purpose in (waste)water treatment development and public health management

The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020

A novel droplet digital PCR human mtDNA assay for fecal source tracking

High Throughput pre-analytical processing of wastewater settled solids for SARS-CoV-2 RNA analyses v1 (protocols.io.btyqnpvw). protocols.io

High Throughput RNA Extraction and PCR Inhibitor Removal of Settled Solids for Wastewater Surveillance of SARS-CoV-2 RNA v1 (protocols.io.btyrnpv6). protocols.io

High Throughput SARS-COV-2, PMMOV, and BCoV quantification in settled solids using digital RT-PCR v1 (protocols.io.btywnpxe). protocols.io

Incubation period and other epidemiological characteristics of 2019 novel Coronavirus infections with right truncation: A statistical analysis of publicly available case data

EpiEstim: estimate time varying reproduction numbers from epidemic curves. R package version

Occurrence of pepper mild mottle virus in drinking water sources in Japan

RNA Viral Community in Human Feces: Prevalence of Plant Pathogenic Viruses

We thank members from the Bonhoeffer and Stadler groups for helpful discussions, Carola Bänziger, Claudia Scheckel (Oncobit AG, Switzerland), Bruno Mueller (Microsynth AG, Switzerland), and Sergey Yakushev (Microsynth AG, Switzerland) for assistance with and/or knowledge exchange on method development. We further thank the operators of the Zurich WWTPs for providing samples; the staff of the San Jose wastewater treatment plant including Payak Sarkar, Noel Enoki, and Amy Wong; the Health Department of Canton Zurich for catchment-specific case numbers; and the California Department of Public Health Covid-19 modelling team for input on the Re estimates and symptom onset to case confirmation delay distribution for the state of California. XFC, TS, CO, TRJ and TK acknowledge funding from the Swiss National Science foundation (Special Call on Coronaviruses; 31CA30_196267 and 31CA30_196538). CO, TRJ and TK further acknowledge discretionary funding from Eawag and